| # | Drug | Count |
|---|---|---|
| 0 | PEMBROLIZUMAB | 8 |
| 1 | DURVALUMAB | 6 |
| 2 | BEVACIZUMAB | 2 |
| 3 | CARBOPLATIN | 2 |
| 4 | NINTEDANIB | 2 |
| 5 | PACLITAXEL | 2 |
| 6 | PACLITAXEL (AIBUMIN-BOUND) | 2 |
| 7 | ACETAMINOPHEN | 1 |
| 8 | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 1 |
| 9 | ANTACID | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DORZOLAMIDE HCL | 1 | 0.0009 |
| 1 | CEMIPLIMAB-RWLC | 1 | 0.0005 |
| 2 | DURVALUMAB | 6 | 0.0003 |
| 3 | LOTEPREDNOL ETABONATE | 1 | 0.0002 |
| 4 | DORZOLAMIDE | 1 | 0.0001 |
| 5 | TRAVOPROST | 1 | 0.0001 |
| 6 | PEMBROLIZUMAB | 8 | 0.0001 |
| 7 | NINTEDANIB | 2 | 0.0001 |
| 8 | BRIMONIDINE TARTRATE | 1 | 0.0001 |
| 9 | CALCITRIOL CAPSULES 0.25 MCG | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 1 | Programmed Death Ligand-1 Blocker [EPC] | 6 | 0.0003 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 9 | 0.0001 |
| 3 | Vitamin D3 Analog [EPC] | 1 | 0.0000 |
| 4 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 5 | Epidermal Growth Factor Receptor Antagonist [EPC] | 1 | 0.0000 |
| 6 | CTLA-4-directed Blocking Antibody [EPC] | 1 | 0.0000 |
| 7 | Microtubule Inhibitor [EPC] | 2 | 0.0000 |
| 8 | Dietary Cholesterol Absorption Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 2 | 0.0000 |